Drew G. Markham - 08 Jun 2026 Form 4 Insider Report for MICROVISION, INC. (MVIS)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
10 Jun 2026, 21:56:50 UTC
Prior SEC filing
05 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Drew G. Markham

Key filing fact

Drew G. Markham filed Form 4 for MICROVISION, INC. (MVIS) on 10 Jun 2026.

Key facts

  • This page summarizes Drew G. Markham's Form 4 filing for MICROVISION, INC. (MVIS).
  • 6 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 10 Jun 2026, 21:56.

Change

  • Previous filing in this sequence was filed on 05 Jun 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001865433 Primary reporting owner

Markham Drew G

Relationship
Officer
Address
18390 NE 68TH STREET, REDMOND
Signature
/s/ Drew G. Markham
Signature date
10 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MVIS transaction

Common Stock

Options Exercise

Transaction value
Shares
+150,000
Change %
+32%
Price
$0.000000*
Shares after
622,308
Date
08 Jun 2026
Ownership
Direct
Footnotes
F1
MVIS transaction

Common Stock

Options Exercise

Transaction value
Shares
+118,800
Change %
+19%
Price
$0.000000*
Shares after
741,108
Date
08 Jun 2026
Ownership
Direct
Footnotes
F1
MVIS transaction

Common Stock

Tax liability

Transaction value
Shares
-77,905
Change %
-11%
Price
$0.3621*
Shares after
663,203
Date
10 Jun 2026
Ownership
Direct
Footnotes
F2, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MVIS transaction Derivative

Restricted Stock Units

Award

Transaction value
Shares
+150,000
Change %
Price
$0.000000*
Shares after
150,000
Date
08 Jun 2026
Ownership
Direct
Underlying class
Common stock
Underlying amount
150,000
Exercise price
$0.000000
Footnotes
F4, F5
MVIS transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares
-150,000
Change %
-100%
Price
$0.000000*
Shares after
0
Date
08 Jun 2026
Ownership
Direct
Underlying class
Common stock
Underlying amount
0
Exercise price
$0.000000
Footnotes
F5, F6
MVIS transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares
-118,800
Change %
-100%
Price
$0.000000*
Shares after
0
Date
08 Jun 2026
Ownership
Direct
Underlying class
Common stock
Underlying amount
0
Exercise price
$0.000000
Footnotes
F6, F7
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 7 footnotes

Footnote F1

Vested restricted stock units, or RSUs, were distributed to the Reporting Person, without payment, in shares of common stock on a unit-for-share basis.

Footnote F2

Represents a withholding tax-related nondiscretionary sell-to-cover transaction completed by the Issuer in accordance with the terms of the award agreement.

Footnote F3

The price reported in column 4 is a weighted average price. These shares were sold by the Issuer in multiple transactions at prices ranging from $0.3509 to $0.3779, inclusive.

Footnote F4

Each RSU represents a contingent right to receive one share of MicroVision common stock.

Footnote F5

RSUs vested on June 8, 2026, on the one-year anniversary of grant, upon determination by the Issuer's Compensation Committee of the level of achievement of performance objectives pursuant to the 2025 Executive Bonus Plan.

Footnote F6

At vesting, converts into shares of common stock on a unit-for-share basis.

Footnote F7

On June 6, 2025, the Issuer's Compensation Committee approved a grant of RSUs, which are scheduled to vest as to 33% on each annual anniversary of the grant date until fully vested on June 6, 2028, subject to the Reporting Person's continued employment with the Issuer on each vesting date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .